Viewing Study NCT00260156


Ignite Creation Date: 2025-12-24 @ 11:28 PM
Ignite Modification Date: 2026-03-03 @ 2:22 AM
Study NCT ID: NCT00260156
Status: COMPLETED
Last Update Posted: 2020-12-17
First Post: 2005-11-29
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Clinical Study to Assess the Effect of Vildagliptin on Beta Cell Function in Drug Naive Patients With Type 2 Diabetes
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module